Thomas E. Ryan - Concepedia

Concepedia

Author

Thomas E. Ryan

Eli Lilly (United States)

Also Known As

Ryan, Thomas E., T E Ryan, Thomas E. Ryan, Thomas Ryan

33

Publications

1.1K

Citations

16

H-Index

68

Concepts

All Affiliations

Eli Lilly (United States)Covance (United States)University of Rochester The Ohio State University University of Utah

TE

About

Thomas E. Ryan is an author at Eli Lilly (United States) specializing in medicine, engineering, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	353
2	Engineering	7	7	724
3	Natural Sciences	5	5	272
4	Health Sciences	2	2	49
5	Applied Physics	1	1	31

Thomas E. Ryan

×

19

Publications

1.1K

Citations

16

H-Index

	Year	Citations
A mixed self-assembled monolayer-based surface plasmon immunosensor for detection of E. coli O157:H7 Anand Subramanian, Joseph Irudayaraj, Thomas E. Ryan Biosensors and Bioelectronics EngineeringPathogen DetectionBiosensing SystemsBiomedical DiagnosticsE. Coli O157	2005	274
Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology Giuseppe A. Papalia, Stephanie A. Leavitt, Maggie A. Bynum, Analytical Biochemistry Bioorganic ChemistryEngineeringBiochemistryNatural SciencesBiomolecular Analysis	2006	116
Mono and dithiol surfaces on surface plasmon resonance biosensors for detection of Staphylococcus aureus Anand Subramanian, Joseph Irudayaraj, Thomas E. Ryan Sensors and Actuators B Chemical PlasmonicsEngineeringBiosensing SystemsBiomedical DiagnosticsSurface Functionalization	2005	102
A global benchmark study using affinity-based biosensors Rebecca L. Rich, Giuseppe A. Papalia, Peter J. Flynn, Analytical Biochemistry EngineeringGlobal Benchmark StudyBioanalysisSensor DesignBiomedical Engineering	2008	97
Real-Time, label-free monitoring of tumor antigen and serum antibody interactions Christine Campagnolo, Katherine J. Meyers, Thomas E. Ryan, Journal of Biochemical and Biophysical Methods Tumor ImmunologyEngineeringMedicineBioanalysisImmunology	2004	83
Localization of ionophore activity in a 20,000-dalton fragment of the adenosine triphosphatase of Sarcoplasmic reticulum. Adil E. Shamoo, Thomas E. Ryan, Peter S. Stewart, Journal of Biological Chemistry Adenosine TriphosphataseMolecular BiologyIonophore Activity20,000-Dalton FragmentSelective Ionophore	1976	76
von Willebrand factor (VWF) propeptide binding to VWF D′D3 domain attenuates platelet activation and adhesion Sri Ranganayaki Madabhushi, Chengwei Shang, Kannayakanahalli M. Dayananda, Blood	2012	49
Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a γ-dominant PPAR α/γ Agonist: Lack of Evidence for Urolithiasis as an Inciting Event Gerald G. Long, Vincent L. Reynolds, Alric Lopez-Martinez, Toxicologic Pathology	2008	40
ISOLATION OF IONOPHORES FROM ION‐TRANSPORT SYSTEMS<sup>fn1</sup> Adil E. Shamoo, Thomas E. Ryan Annals of the New York Academy of Sciences BiochemistryMembrane TransportIon ChannelsMedicineIon Process	1975	35
Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents Richard A. Byrd, Steven D. Sorden, Thomas E. Ryan, Endocrinology Focal C-cell HyperplasiaCarcinogenicity StudiesPathologyPharmacotherapyTransgenic Mice	2015	31

Page 1